 serum level solubl interleukin receptor interleukin diffus limit scleroderma effect chlorambucil studi patient system sclerosi ssc serum level solubl interleukin receptor interleukin neopterin indic lymphocyte/monocyt activ earli untreat patient ssc diffus limit level patient durat diseas chlorambucil therapi pharmacolog alter marker humor cell immun accur reflect clinic efficaci chlorambucil